Luuk B. Hilbrands

A RANDOMIZED DOUBLE-BLIND, MULTICENTER PLASMA CONCENTRATION CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF ORAL MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION AFTER KIDNEY TRANSPLANTATION1

Teun van Gelder, Luuk B. Hilbrands, Yves Vanrenterghem et al. · Transplantation · 1999 · 540 citations

Medicine, Pharmacokinetics, Pharmacology +17

COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration

Luuk B. Hilbrands, Raphaël Duivenvoorden, Priya Vart et al. · Nephrology Dialysis Transplantation · 2020 · 411 citations · Full text

Medicine, Infectious Diseases, Nephrology +13

Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA

Alberto Ortíz, Mario Cozzolino, Danilo Fliser et al. · Nephrology Dialysis Transplantation · 2020 · 377 citations · Full text

Medicine, Nephrology, Dialysis +11

Deep Learning–Based Histopathologic Assessment of Kidney Tissue

Meyke Hermsen, Thomas de Bel, Marjolijn den Boer et al. · Journal of the American Society of Nephrology · 2019 · 350 citations · Full text

Medicine, Biomedical Engineering, Pathology +14

Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4+CD25+ regulatory T cells

Jeroen J. A. Coenen, Hans J. P. M. Koenen, Esther van Rijssen et al. · Blood · 2005 · 248 citations · Full text

Life Sciences, Cell Biology, Immunology +14